Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk.
Ren P, Cao Z, Mo R, Liu Y, Chen L, Li Z, Zhou T, Lu J, Liu Y, Guo Q, Chen R, Zhou H, Xiang X, Cai W, Wang H, Bao S, Xu Y, Gui H, Xie Q.
Ren P, et al. Among authors: wang h.
Expert Opin Biol Ther. 2018 Oct;18(10):1085-1094. doi: 10.1080/14712598.2018.1518423. Epub 2018 Sep 13.
Expert Opin Biol Ther. 2018.
PMID: 30182763